simplyStocks
Explore all companies →
Stryker
SYK · NYSEMedical Devices
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
Inputs &supplyTitanium, electronics, co…R&D &regulatorsEngineering, trials, FDA…ManufacturingImplants, robots, devicesProductsMako, implants, MedSurg,…Payers &distributionGPOs, distributors, insur…Providers &patientsHospitals, surgeons, pati…TIAlloy suppliersCMPComponent vendorsCMContract manufacturersSR&EStryker R&D & engineeringFDAFDA / EMASYKStrykerOIOrthopaedic implantsMAKOMako SurgicalMIMedSurg instrumentsNEUNeurotechnologyGPOGPOs & distributorsP&GPayers & governmentsHOSPHospitals & surgeonsPATPatients
Company details
Market cap
$120B
P/E ratio
40×
Div yield
1.0%
EPS (TTM)
$8.40
Profit margin
13%
Rev. growth
+11%
Revenue
$25B
Free cash flow
$4.3B
In plain English
Stryker is one of the world's biggest medical-technology companies: it makes the artificial hips and knees surgeons implant, the Mako robot arm that helps place them, plus a huge spread of hospital gear — surgical power tools, patient beds and stretchers, brain-bleed and stroke devices, and the communication systems that run an operating room. It grows largely by buying smaller medtech firms (Mako, Wright Medical, Vocera, and in 2025 the clot-removal specialist Inari).
In simple terms
What Stryker really sells
Stryker is one of the world's biggest medical-technology companies: it makes the artificial hips and knees surgeons implant, the Mako robot arm that helps place them, plus a huge spread of hospital gear — surgical power tools, patient beds and stretchers, brain-bleed and stroke devices, and the communication systems that run an operating room. It grows largely by buying smaller medtech firms (Mako, Wright Medical, Vocera, and in 2025 the clot-removal specialist Inari).
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
Moderate
SteadierMore speculative
Why this rating?